Our leadership team
Diverse leadership team with the experience to scale
Our passion is people, giving the best to our teams, patients and our partners.
Manuel O. Méndez
Chief Executive Officer
Ali Kiboro
Chief Financial Officer
Dr. Christian Fischer
Chief Medical Officer
Nadia Altomare
Chief Commercial Officer
Dr. Michael Hausmann
Chief Technology Officer
Viviane Montarnal
General Counsel & Compliance Officer
Steven Zuiderwijk
Chief Strategy & Business Development Officer
Michael Campbell
Chief Regulatory Affairs & Quality Officer
David TenBarge
General Manager, ALBA
Matt Howson
Chief Manufacturing Operations Officer MosaiQ
Trending Topics
Recent press, briefings and insights helping you stay informed on AliveDx news.
-
Join us at AABB 2024!
Meet the Alba team at the AABB Annual Meeting to learn how our high-quality blood bank reagents can drive value in your lab! Sign up for a booth meeting with your Account Executive today.
-
Join us at Medlab Africa!
Maximizing your valuable time and resources is essential for efficient laboratory operations. Experience firsthand the transformative capabilities of MosaiQ and LumiQ (IFA). Both solutions are designed to deliver actionable diagnostic insights more quickly and cost-effectively, helping you achieve more with
-
AliveDx receives ISO 22301:2019 Certification
We are proud to announce that our manufacturing facility in Edinburgh, Scotland has been awarded the ISO 22301:2019 Security and resilience certificate. “Gaining the ISO 22301 standard for the UK site underlines AliveDx’s commitment to the needs of our customers.
-
AliveDx Receives ISO 13485:2016 and MDSAP Certifications for Its Manufacturing Site in Switzerland, for Both Autoimmune Disease and Allergy Testing
We are proud to announce that our manufacturing facility in Eysins, Switzerland has been granted ISO 13485:2016 and Medical Device Single Audit Program (MDSAP) certifications for the design, development, production, and distribution of in-vitro diagnostic test kits and reagents for
-
AliveDx Receives IVDR-CE Mark for Multiplexed Assay to Accurately Detect Celiac Disease (CD) on the MosaiQ® System
Eysins, September 3, 2024 At AliveDx, our mission is to empower diagnostic insights, transform patient care, and innovate for life. We are excited and proud to announce AliveDx has received IVDR-CE mark certification for its multiplexed MosaiQ AiPlex™ CD microarray
-
AliveDx Receives IVDR-CE Mark for Multiplexed Assay to Accurately Detect Celiac Disease (CD) on the MosaiQ® System
At AliveDx, our mission is to empower diagnostic insights, transform patient care, and innovate for life. We are excited and proud to announce AliveDx has received IVDR-CE mark certification for its multiplexed MosaiQ AiPlex™ CD microarray immunoassay, designed to improve
